SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5066)12/9/1997 10:59:00 AM
From: aknahow  Read Replies (1) | Respond to of 17367
 
TO ALL I was wrong again about XOMAs Swiss Bank. Xoma uses Credit Swiss which owns First Boston. The merger of UBS and Swiss Bank Corp in no way will he any impact on analyst coverage of Xoma. This is the second time I have done this. Perhaps if all the Swiss Banks merge into one I will no longer make this mistake. Mea culpa, mea culp, mea maxima culpa. (for Andy, think he or a Swiss persons said he likes to see me admit this). Question, Andy. Why does one mind only knaw and say why did you say that? Are you sure about what you said? Why doesn't ones mind just say, Hey! That's the wrong bank. Don't post anything dope!



To: aknahow who wrote (5066)12/9/1997 11:28:00 AM
From: chirodoc  Read Replies (1) | Respond to of 17367
 
<<<<<BTW if it was not for market impact I would be content with Wildrose on the web, at no cost.

......never heard of wildrose--i will look it up.

.....i can't imagine that a good financial deal for xoma and some successful clinical trials over the next 6-12 months won't do a lot for the stock price--we may be in this a bit early but i agree that the outlook is bright.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News